MedPath

Pre-hospital Rule-out of Acute Coronary Syndrome

Not Applicable
Conditions
Acute Coronary Syndrome
Interventions
Diagnostic Test: Pre-hospital rule-out strategy
Registration Number
NCT05466591
Lead Sponsor
Radboud University Medical Center
Brief Summary

Patients with chest pain suspected for non ST-segment elevation acute coronary syndrome (NSTE-ACS) are routinely transferred to the emergency department (ED). A point-of-care (POC) troponin measurement might enable ambulance paramedics to identify low-risk patients in whom ED evaluation is not necessary. The ARTICA trial aims to assess the healthcare cost reduction and safety of a pre-hospital rule-out strategy using a single POC troponin measurement.

Detailed Description

Patients with chest pain suspected of a NSTE-ACS are screened by ambulance paramedics. The HEAR score (HEART score without the Troponin component) is assessed and patients with a HEAR score of ≤3 are included. The patients are randomised to 1) pre-hospital rule-out with POC troponin measurement (intervention group) and 2) direct transfer to the ED (standard care group). Primary outcome is healthcare costs after 30 days.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
866
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Pre-hospital rule-out strategyPre-hospital rule-out strategyPatients undergo a point-of-care troponin T measurement. If troponin is low, an acute coronary syndrome is considered ruled-out and the care for the patient is transferred to the general practitioner. If troponin is elevated, the patient is immediately transported to the emergency department.
Primary Outcome Measures
NameTimeMethod
Costs from a healthcare perspective (all costs related to healthcare consumption in-hospital, all outpatient visits including diagnostic tests and general practitioner consultations)30 days

Healthcare costs consist of all costs related to healthcare consumption

Secondary Outcome Measures
NameTimeMethod
Safety: all cause death, acute coronary syndrome, unplanned revascularisation30 days

Major adverse cardiac events (all cause death, ACS, unplanned revascularisation)

Costs from a societal perspective (all health effects and changes in resource use caused by an intervention)30 days

Costs from a societal perspective are defined as the sum of the healthcare costs and the costs from productivity losses.

Safety (all cause death, acute coronary syndrome, unplanned revascularisation)12 months

Major adverse cardiac events (all cause death, ACS, unplanned revascularisation)

Trial Locations

Locations (1)

RadboudUMC

🇳🇱

Nijmegen, Netherlands

© Copyright 2025. All Rights Reserved by MedPath